Baricitinib provides rapid and sustained improvements in absolute EASI and SCORAD outcomes in adults with moderate-to-severe atopic dermatitis.
The Journal of dermatological treatment
View this publicationMember
Medical Faculty, University of Bonn University Hospital of Bonn Sigmund-Freud-Strasse 25 53127 Bonn
The Journal of dermatological treatment
View this publicationThe Journal of dermatological treatment
View this publicationJournal of the European Academy of Dermatology and Venereology : JEADV
View this publication